Metformin does not improve survival in unselected patients with metastatic hormone-sensitive prostate cancer (mHSPC), but the drug may improve survival and other outcomes in those with high-volume ...
Vistra Corp. (VST) shares rallied 16.3% in the last trading session to close at $107.88. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...